← Leaderboards
Jessica Finlay-Schultz
University Of Colorado Denver
$172,914
Attributed
$172,914
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $61K · FY2014–16$100K$75K$50K$25K$0
'14
'15
'16
Funding mix
By agency
NIH$172,914 · 1
By mechanism
F32$172,914 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Melanie G Cree$5,579,720
- Catherine M Jankowski$3,885,327
- Jennifer Richer-Mouchantat$2,679,313
- Nicole Renee Tartaglia$8,137,304
- David L Bain$4,362,761
Others in their field
Top investigators on “Estrogen Receptors”
- Susan E. Hankinson · University Of Massachusetts Amherst$30,736,590
- David Heimbrook · Leidos Biomedical Research, Inc.$29,594,272
- Bert W O'Malley · Baylor College Of Medicine$28,464,172
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Howard N Hodis · University Of Southern California$24,496,214
- Donald P McDonnell · Duke University$19,513,822
Research focus
Estrogen ReceptorsEstrogensEffective TherapyEstrogen Receptor PositiveAndrogen AntagonistsAnti-ProgestinCultured CellsCleaved CellErbb2 GeneBiological MarkersBreast Cancer CellAnimalsBreast Cancer DiagnosisBreast Cancer ModelApoptosisAgonistAnalogCellsAndrogen ReceptorCell Cycle KineticsCell GrowthCell LineCell ProliferationFreezing
Grant awards (3)
Tumor-specific actions of progestins in patient-derived breast cancer models$61,010
F32 · FY2016 · CA · contact PI
Tumor-specific actions of progestins in patient-derived breast cancer models$57,962
F32 · FY2015 · CA · contact PI
Tumor-specific actions of progestins in patient-derived breast cancer models$53,942
F32 · FY2014 · CA · contact PI